# Assessment and optimization plan for enhancing public medical laboratory services in the Kyrgyz Republic

**Authors:** Taalaigul Sabyrbekova, Elmira Turkmenova, Ping Ling Yeoh, Olga Slobodskaya, Cebele Wong, Brian Chin, Steve Zimmerman, Steve Zimmerman, Julia Robinson

PMC · DOI: 10.1371/journal.pgph.0004840 · PLOS Global Public Health · 2025-07-07

## TL;DR

This paper outlines a plan to improve public medical laboratory services in the Kyrgyz Republic by assessing weaknesses and creating an optimization strategy.

## Contribution

A novel approach to assess and optimize laboratory services in low-income settings using a WHO tool and a master plan for improvement.

## Key findings

- Five major weaknesses were identified: poor lab organization, documentation issues, biosafety problems, biorisk management gaps, and unmet public health functions.
- A master plan was developed to address these issues through equipment procurement, staff training, and network establishment.
- The approach can serve as a model for other countries facing similar challenges in laboratory service optimization.

## Abstract

Middle-income and especially low-income countries continuously seek ways to efficiently utilize their public funds to provide access to quality healthcare for their population. The government of the Kyrgyz Republic is embarking on a Strengthening Regional Health Security Project for the optimization and centralization of medical laboratories, which will be implemented as a pilot in two major cities and two regions of the country to improve essential laboratory testing for disease surveillance and diagnostics. Representative state-funded laboratories (6 bacteriological public health laboratories and 11 clinical diagnostic laboratories) were assessed using the World Health Organization’s Laboratory Assessment Tool that covered the provision of services, condition of facilities, equipment, financing, reagent procurement, workflow, regulatory documents, and quality control and assurance. The five greatest weaknesses across the laboratories were identified as: (i) weak organization and management of laboratory, (ii) insufficient documentation management, (iii) inadequate facilities for biosafety, (iv) lack of biorisk management, and (v) unmet public health functions. The results of the assessment informed the design and development of a laboratory optimization master plan, including procurement of equipment and reagents, professional development of laboratory staff, and establishing laboratory networks starting with selected laboratories in two regions of the country. The restructuring, upgrading, and continuous quality improvement of laboratory networks will be achieved through strengthening governance capacity for the national laboratory system including regulation, standards, planning, financing, management, monitoring, and studies for innovative solutions. The approach to assessing the current situation and creating an improvement plan for optimizing laboratory services may be useful to countries facing similar challenges.

## Full-text entities

- **Diseases:** viral hepatitis (MESH:D014777), critically ill (MESH:D016638), syphilis (MESH:D013587), CDLs (MESH:D007757), herpes virus (MESH:D020031), inflammation (MESH:D007249), anemia (MESH:D000740), respiratory, gastrointestinal and systemic infections (MESH:D012141), cancers (MESH:D009369), endocrine disorders (MESH:D004700), AMR (MESH:D060467), COVID-19 (MESH:D000086382), coagulation (MESH:D001778), Dangerous Infections (MESH:D007239), TB (MESH:D014376), transmissible diseases (MESH:D017096), CDL (MESH:D003635), thyroid function (MESH:D013966), HIV (MESH:D015658)
- **Chemicals:** PGPH-D-24-03057 (-), lipid (MESH:D008055), glucose (MESH:D005947)
- **Species:** Human immunodeficiency virus (species) [taxon 12721], Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12233281/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12233281/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12233281/full.md

---
Source: https://tomesphere.com/paper/PMC12233281